Timothy S Keizer
Overview
Explore the profile of Timothy S Keizer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCleskey T, Ehler D, Keizer T, Asthagiri D, Pratt L, Michalczyk R, et al.
Angew Chem Int Ed Engl
. 2007 Mar;
46(15):2669-71.
PMID: 17348063
No abstract available.
2.
Fontenot A, Keizer T, McCleskey M, Mack D, Meza-Romero R, Huan J, et al.
J Immunol
. 2006 Sep;
177(6):3874-83.
PMID: 16951350
Chronic beryllium disease is a lung disorder caused by beryllium exposure in the workplace and is characterized by granulomatous inflammation and the accumulation of beryllium-specific, HLA-DP2-restricted CD4+ T lymphocytes in...
3.
Del Sesto R, Baker G, Baker S, Scott B, Keizer T, Burrell A, et al.
Chem Commun (Camb)
. 2006 Jan;
(3):272-4.
PMID: 16391731
An intriguing and novel charge-transfer complex between dimethyldihydrophenazine and diethylviologen has been crystallized from an ionic liquid at room temperature, resulting in an interesting stacking motif of interrupted D***A***D type...
4.
Plieger P, Ehler D, Duran B, Taylor T, John K, Keizer T, et al.
Inorg Chem
. 2005 Aug;
44(16):5761-9.
PMID: 16060628
The ligand 4,5-dicarboxyimidazole (H(2)DCI) and its methyl derivative 1-methyl-4,5-dicarboxyimidazole (H(2)MDCI) have been shown to bind to Be(II) forming a zwitterionic species that has been structurally characterized. A new dicarboxyimidazole-based polymer...
5.
Keizer T, Sauer N, McCleskey T
J Inorg Biochem
. 2005 Apr;
99(5):1174-81.
PMID: 15833341
Beryllium speciation at physiological conditions is critical to understanding chronic beryllium disease (CBD). The MHC-class II receptor alleles that have been linked to CBD have more than six carboxylates in...
6.
Keizer T, Scott B, Sauer N, McCleskey T
Angew Chem Int Ed Engl
. 2005 Mar;
44(16):2403-6.
PMID: 15761894
No abstract available.
7.
Plieger P, John K, Keizer T, McCleskey T, Burrell A, Martin R
J Am Chem Soc
. 2004 Nov;
126(44):14651-8.
PMID: 15521785
The structures of a series of beryllium containing complexes have been optimized at the B3LYP/6-31G(d) level and their (9)Be magnetic shielding values have been determined using B3LYP/6-311G+g(2d,p) and the gauge-including...
8.
Keizer T, Sauer N, McCleskey T
J Am Chem Soc
. 2004 Aug;
126(31):9484-5.
PMID: 15291520
We report the rational design of ligands that selectively bind beryllium. We selected two ligands to design Be based on binding polynulear species with a Be-O-Be motif: 2-hydroxyisophthalic acid (HIPA)...
9.
Keizer T, De Pue L, Parkin S, Atwood D
J Am Chem Soc
. 2002 Feb;
124(9):1864-5.
PMID: 11866594
The Salen(tBu) ligand and its derivatives were used to prepare binuclear boron complexes. These compounds have the formula, L(BBr2)2 (L = Salpen(tBu) and Salben(tBu)). These are formed from the reaction...